2-Chloro-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide, 97%, 50mg

3,5-Dibromo-4-methylpyridine>98.0%(GC)(T)5g

1-O-tert-Butyl 6-O-methyl 3,4-dihydro-2H-1,5-naphthyridine-1,6-dicarboxylate, 95+%, 100mg

(4-(Di-p-tolylamino)phenyl)boronic acid, 98%, 5g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 95.0%, 100mg

[1,2-Bis(diphenylphosphino)ethane]nickel(II) Dichloride>96.0%(T)25g

5-Hydroxypyridine-2-carboxylic Acid>98.0%(HPLC)(T)5g

1-tert-Butyl 3-methyl 3-benzyl-4-oxopiperidine-1,3-dicarboxylate, 97%, 2g

2-hydrazinyl-N,6-dimethylpyrimidin-4-amine, 95.0%, 250mg

4-METHOXY-6-METHYL-2H,5H,6H,7H,8H-[1,3]DIOXOLO[4,5-G]ISOQUINOLINE, 95%, 50mg

ETHYL 2-(2-FLUOROPYRIDIN-4-YL)ACETATE, 95%, 250mg

Rotilabo®-Probenbeutel, LDPE, Wandstärke 50 µm, B 50 x H 80 mm, Mit Druckleistenverschluss, 1000 Stück

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 10g